Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure-Reference-Cited by-同舟云学术

Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure

Published:2010-01 Issue:1 Volume:47 Page:79-81
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Stegmann Sophie,Manea Maria Elena,Charpentier Charlotte,Damond Florence,Karmochkine Marina,Laureillard Didier,Si-Mohamed Ali,Weiss Laurence,Piketty Christophe

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference17 articles.

1. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli;Hizi;Virology,1991

2. Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV;Witvrouw;Aids,1999

3. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis;Witvrouw;Antivir Ther,2004

4. In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors;Desbois;Antimicrob Agents Chemother,2008

5. HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro;Roquebert;J Antimicrob Chemother,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds;International Journal of Molecular Sciences;2023-03-21

2. Modeling cerebellar limb dysmetria and impaired spatial memory in rats using lamivudine: A preliminary study;Journal of Chemical Neuroanatomy;2020-11

3. Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience;Journal of Medical Virology;2016-01-05

4. Maraviroc: a review of its use in HIV infection and beyond;Drug Design, Development and Therapy;2015-10

5. Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates;PLOS ONE;2015-08-06